Home > Boards > US Listed > Biotechs >

Micromet, Inc (f/k/a MITI)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/8/2020 10:10:44 AM - Followers: 13 - Board type: Free - Posts Today: 0


Micromet, Inc. (NASDAQ: MITI)







Company Information:
2110 Rutherford Road
Carlsbad, CA 92008
Phone: (760) 494-4200





Micromet, Inc. (NASDAQ: MITI) is a biotechnology company focused on the research and development of novel biological products for the treatment and control of cancer, inflammation and autoimmune diseases. All of these indication areas are characterized by significant unmet medical needs.

Using its antibody technology platforms, Micromet´s goal is to create novel drugs that are highly specific, effective and well tolerated in patients. The Company currently has four candidates, adecatumumab (MT201), MT293 (TRC093), MT110 and blinatumomab (MT103), in clinical trials against major cancer indications, including metastatic breast cancer and relapsed non-Hodgkin's lymphoma (NHL). In addition, Micromet´s pipeline includes a number of preclinical drug candidates and several compounds at research stage.
The Company has strategic collaborations or license agreements with Bayer-Schering, Sanofi-aventis, MedImmune, Merck Serono, Morphotek, Nycomed and TRACON Pharmaceuticals.


Christian Itin, PhD, President, Chief Executive Officer and Director
Barclay Phillips, Senior Vice President and Chief Financial Officer
Patrick A. Baeuerle, PhD, Professor for Immunology, Senior Vice President and Chief Scientific Officer
Jan Fagerberg, M.D., Senior Vice President and Chief Medical Officer
Jens Hennecke, PhD, Senior Vice President Business Development
Mark Reisenauer, Senior Vice President and Chief Commercial Officer
Matthias Alder, LL.M, Senior Vice President, General Counsel and Secretary

Presentation & Webcast Archive: 



BiTE Antibody Platform:




Investor Calendar: 



Recent News: 






Transfer Agent:



Share Structure:

68,985,005 Outstanding as of Nov 2, 2009
Need updated info here


Investor Relations:

(240) 235-0250


Contact Information Investors:

Ines-Regina Buth (760) 494-4235 (US) +49 (0)89 895277 221 (Europe) ines.buth@micromet-inc.com

Media Europe: Evelyn Wolf +49 (0)89 895277 220 evelyn.wolf@micromet-inc.com

Media US: Susan Noonan (212) 966-3650 susan@sanoonan.com






All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.


Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.


Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:




#196   https://finance.yahoo.com/news/biotech-stock-review-mitesco-launch-120010528.htm goingforittoday 05/08/20 10:10:44 AM
#195   Nice tele-health news today , lets see blindjohn 05/08/20 09:34:58 AM
#194   I haven’t been in this in over 8 fink 05/07/20 08:46:05 PM
#193   Bids keep getting hit, although there was a ThoroughBread 05/07/20 11:11:13 AM
#192   ~ Monday! $MITI ~ Earnings posted, pending or Penny Roger$ 02/26/12 09:30:07 AM
#191   Look a few of my feloow MITIers are fink 02/05/12 05:38:16 PM
#190   Maybe if another bidder comes in. fink 01/26/12 05:02:00 PM
#189   Nope, It won't. This is it. and it fink 01/26/12 02:33:57 PM
#188   I'm too very disapointed. I was looking at fink 01/26/12 02:30:51 PM
#187   Is $11 Reasonable? Not to Me It Isn't! DocLee 01/26/12 09:45:51 AM
#186   I wonder if the share price will go bradfrogger 01/26/12 09:18:45 AM
#185   MITI buy-out by AMGN for $11/share? Will north40000 01/26/12 08:41:03 AM
#184   Man I really hate looking at the daily fink 01/11/12 11:05:17 AM
#183   Yeulp! $8.50 is all she is good for. fink 01/11/12 09:44:05 AM
#182   Yeah since I have $25K wrapped up in fink 01/10/12 12:45:50 PM
#181   Gives you a warm feeling, doesn't it!!! DocLee 01/10/12 12:41:24 PM
#180   Its a $120- $140 stock with FDA approval. fink 01/10/12 12:17:33 PM
#179   $8.4 today and going up like a rocket! DocLee 01/10/12 11:38:34 AM
#178   Still looking to break above $8 on no fink 01/09/12 10:19:30 AM
#177   The National Cancer Institute Shows Confidence in Blinatumomab. DocLee 01/09/12 09:30:39 AM
#176   DNDN up 50% this morning. That spells good fink 01/05/12 10:11:04 AM
#175   Always a good day for the first day fink 01/03/12 04:37:14 PM
#174   Impressive Trial Results for Blinatumomab at ASH 2011 DocLee 12/19/11 11:31:38 AM
#173   Clinical Trials Provide Further Evidence for Blinatumomab's Efficacy. DocLee 12/11/11 01:42:11 PM
#172   Over the past year, Micromet has traded in fink 11/22/11 02:20:09 PM
#171   American Society of Hematology - December Meeting DocLee 11/09/11 05:27:13 AM
#170   MITI $6.31 Micromet beats by $0.06, mlkrborn 11/08/11 10:10:50 AM
#169   MITI just wants to go Green fink 10/25/11 10:51:37 AM
#168   It tried to punch through that .45 line today. fink 10/24/11 04:27:25 PM
#167   I know, even for the established Pharmas out fink 10/24/11 08:18:43 AM
#166   They are all risky these days... KarinCA 10/23/11 10:54:34 PM
#165   Filings: Filings: KarinCA 10/23/11 10:53:51 PM
#164   News: http://ih.advfn.com/p.php?pid=news&symbol=MITI KarinCA 10/23/11 10:53:19 PM
#163   MITI chart: KarinCA 10/23/11 10:52:11 PM
#162   Nice volume at the open today. fink 10/21/11 09:32:39 AM
#161   Now, this is what I call an uplifting commentary! DocLee 10/16/11 02:43:51 PM
#160   7:34AM Micromet obtains FDA feedback on registration strategy surf1944 10/13/11 08:31:50 AM
#159   Morning after the company update! Looking good so far. fink 09/21/11 09:51:47 AM
#158   http://cc.talkpoint.com/ubsx001/091911a_im/?entity=31_PX0BDX0 $1BB from Amgen fink 09/20/11 06:23:05 PM
#157   Micromet has collaborations with a number of leading fink 09/20/11 05:00:45 PM
#156   And if ya bought the Dip, you'd be fink 09/20/11 11:06:49 AM
#155   Awesome. Ha Ha. Laughed my butt off. buffalo2222 09/19/11 08:48:57 PM
#154   Look at Tex taking a look in! fink 09/19/11 11:03:31 AM
#153   $300K whats your gut feeling now kind sir? texkengold 09/19/11 10:33:11 AM
#152   Don't worry Buffalo. Its cool fink 09/18/11 09:58:15 PM
#151   Watch this Youtube video. Funny buffalo2222 09/17/11 07:38:25 PM
#150   Yea thats always funny what they put out. fink 09/14/11 03:32:45 PM
#149   Encouraging - BUT with a sting in its tail! DocLee 09/13/11 08:17:42 AM
#148   Goldman Sachs Starts Micromet (MITI) at Neutral n4807g 08/17/11 12:46:51 PM
#147   Nice article. Thanks Yahoo, but could ya name FreeNorth 08/12/11 02:11:26 AM
Consent Preferences